HRGN
HRGN
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$394K
Insider Sales
0
$0
Total Volume
$394K
1 transactions
Net Activity
+$394K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
He Junli
CEO
$394K total
Quick Actions
HRGN has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at HRGN (HRGN) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $394K.
The net insider activity for HRGN shows a net buying bias of $394K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by He Junli (CEO), who traded 368.6K shares valued at $394K on Sep 11, 2026.
Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
Harvard Apparatus Regenerative Technology Inc. (HRGN) Stock Price, News, Quote & History
Harvard Apparatus Regenerative Technology Secures $300,000 8% Bridge Note From CEO Junli He
HRGN | Harvard Apparatus Regenerative Technology Inc. Stock Overview (U.S.: OTC)
What is the current Price Target and Forecast for Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Insider Stock Purchases: September 28, 2026
FAQs About HRGN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for HRGN.